US EditionSen. Josh Hawley Amps up Pressure Campaign on FDA Chief to Limit Medication Abortion
Sen. Hawley demands FDA finish its safety review of medication abortion amid concerns over political delays and rising abortion rates since Roe was overturned.
- On Wednesday, Missouri U.S. Sen. Josh Hawley sent a two-page letter pressing FDA Commissioner Marty Makary to finish a study and answer three questions about mifepristone by Dec. 15, calling the pace "totally unacceptable."
- The campaign began Tuesday when anti-abortion leaders called for Makary's removal after a Bloomberg Law report, and Missouri U.S. Sen. Josh Hawley cited rising abortion counts since Roe in his letter.
- Mifepristone is approved for up to 10 weeks gestation and telehealth prescribing, while ACOG and AMA say major adverse events occur in less than 0.32% with almost no risk of death.
- The Department of Health and Human Services spokesperson defended the review pace as necessary for "gold‑standard science and evidence‑based reviews," while Americans United for Life CEO John Mize said political calculations have stalled the review after meeting Marty Makary.
- Reducing access to mifepristone has become central to the anti‑abortion movement since the Supreme Court overturning of nationwide abortion right , and anti‑abortion medical organizations unsuccessfully sought guideline changes in 2024, with Hawley married to Erin Morrow Hawley linking him to that legal network.
19 Articles
19 Articles
Sen Josh. Hawley amps up pressure on FDA chief to limit medication abortion
U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)WASHINGTON — Missouri U.S. Sen. Josh Hawley is ratcheting up pressure on the U.S. Food and Drug Administration to finish a study into medication abortion and to change its prescribing guidelines, sending a letter to Commissioner Marty Makary on Wednesday that the pace of the review is “totally unacceptable.” Th…
Missouri Sen. Hawley amps up pressure campaign on FDA chief to limit medication abortion • SC Daily Gazette
U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)WASHINGTON — Missouri U.S. Sen. Josh Hawley is ratcheting up pressure on the U.S. Food and Drug Administration to finish a study into medication abortion and to change its prescribing guidelines, sending a letter to Commissioner Marty Makary on Wednesday that the pace of the review is “totally unacceptable.” Th…
Nebraska Examiner
Missouri Sen. Hawley amps up pressure campaign on FDA chief to limit medication abortion
U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)WASHINGTON — Missouri U.S. Sen. Josh Hawley is ratcheting up pressure on the U.S. Food and Drug Administration to finish a study into medication abortion and to change its prescribing guidelines, sending a letter to Commissioner Marty Makary on Wednesday that the pace of the review is “totally unacceptable.” Th…
Senator Hawley Hates Abortion Pills
Context . . .The number of U.S. abortions keep rising and recent studies suggest that 63% of all women now rely on abortion pills to terminate pregnancies. Our perspective here is gloomy but we find that this axiom holds true: Limiting technology is nearly impossible this might be a losing battle given that even the most strident Republican women often vote for abortion access by way of secret ballot. Remember that even Red State Missouri voter…
Coverage Details
Bias Distribution
- 94% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
